Clinical trial
A Multi-center, Randomized, Study to Compare the Effectiveness of Sirolimus-eluting Stent (Ultimaster Stent) or Everolimus-eluting Stent (XIience Alpine Stent) for Long Coronary Lesions.
NCT03484234 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Study to Compare the Effectiveness of Sirolimus-eluting Stent (Ultimaster Stent) or Everolimus-eluting Stent (XIience Alpine Stent) for Long Coronary Lesions.
- Lead sponsor
- Seung-Jung Park
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 27, 2018
- Completion date
- September 6, 2019
- Enrollment
- 36 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.